For example, in NSCLC patients who received 99mTc-labeled annexin V as a marker of cell death, early chemotherapy-induced tumor-specific annexin V uptake on SPECT significantly correlated with later RECIST-defined tumor responses although some patients with RECIST-defined stable disease also had tumor annexin V uptake [12]. This evidence concerns the gene ANXA5 and neoplasm.